![]() This program is administered by Medical Security Card Company, LLC, Tucson, AZ. You may contact customer care anytime with questions or concerns, to cancel your registration, or to obtain further information. Cannot be used in conjunction with insurance. Members are required to pay for all prescription purchases. This program does not make payments directly to pharmacies. The range of the discounts will vary depending on the type of prescription and the pharmacy chosen. Discounts are available exclusively through participating pharmacies. The pricing estimates given are based on the most recent information available and may change based on when you actually fill your prescription at the pharmacy.ĭISCOUNT ONLY - NOT INSURANCE. In ascending order, Europe, North America and Oceania remain the three regions with a prevalence of "ecstasy" use that is above the global average.Prescription prices may vary from pharmacy to pharmacy and are subject to change. While "ecstasy" use has been declining globally, it seems to be increasing in Europe. There is also an indication of increased manufacturing activity in Central America and an increase in the influence of Mexican drug trafficking organizations in the synthetic drugs market within the region.įigures for amphetamine seizures have also gone up, particularly in the Middle East, where the drug is available largely in pill form, marketed as "captagon" pills and consisting largely of amphetamine.Įurope and the United States reported almost the same number of amphetamine laboratories (58 versus 57) in 2011, with the total number remaining fairly stable compared with 2010. ![]() Methamphetamine manufacture seems to be spreading as well: new locations were uncovered, inter alia, in Poland and the Russian Federation. Seizures of crystalline methamphetamine, however, increased to 8.8 tons, the highest level during the past five years, indicating that the substance is an imminent threat. Methamphetamine pills remain the predominant ATS in East and South-East Asia where 122.8 million pills were seized in 2011, although this was a 9 per cent decline compared with 2010 (134.4 million pills). Methamphetamine continues to be the mainstay of the ATS business it accounted for 71 per cent of global ATS seizures in 2011. Mexico clocked the largest amount of methamphetamine seized, more than doubling, from 13 tons to 31 tons, within the space of a year, thus surpassing the United States for the first time. The estimated annual prevalence of ATS use in the region is higher than the global average.Īt the global level, seizures have risen to a new high: 123 tons in 2011, a 66 per cent rise compared with 2010 (74 tons) and a doubling since 2005 (60 tons). While use is steady in the traditional markets of North America and Oceania, there seems to be an increase in the market in Asia's developed economies, notably in East and South-East Asia, and there is also an emerging market in Africa, an assessment that is borne out by increasing diversions of precursors, seizures and methamphetamine manufacture. The prevalence of "ecstasy" in 2011 (19.4 million, or 0.4 per cent of the population) was lower than in 2009. In 2011, an estimated 0.7 per cent of the global population aged 15-64, or 33.8 million people, had used ATS in the preceding year. The use of ATS, excluding "ecstasy", remains widespread globally, and appears to be increasing in most regions. There are signs that the market for amphetamine-type stimulants (ATS) is expanding: seizures and consumption levels are increasing, manufacture seems to be spreading and new markets are developing.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |